Business Law
Employment
What a Headache! The Third Circuit finds that a plaintiff’s migraines were not a serious health condition under the FMLA
This decision highlights what constitutes a “serious condition” under FMLA, and the standards that should be applied in assessing such claims. This decision highlights what ...
Intelectual Property (IP)
What’s Trending In Trademarks October 2024: T.I. and Tiny Win $71.5M for OMG Girlz; Second Circuit Holds against 1-800 Contacts In Keyword Ads Case
The Third Time’s a charm for OMG Girlz with $71.5M Verdict A U.S. District Court jury in the Southern District of California awarded $71.5 million ...
Intelectual Property (IP)
Federal Circuit vacates District Court’s denial of Antisuit Injunctions in FRAND Case
Support IPWatchdog with an individual sponsorship: Click here “[T]he Federal Circuit noted that nothing in Microsoft required a patent license to result for the U.S. ...
Intelectual Property (IP)
Goodwin
Accord BioPharma Inc. announced on October 14, 2024 that the FDA had approved IMULDOSA, a biosimilar product to Johnson & Johnson’s STELARA (ustekinumab). IMULDOSA is ...
Intelectual Property (IP)
Goodwin
As previously reported, the District Court for the Northern District of West Virginia, on September 24, 2024 denied Regeneron’s motion for a preliminary injunction to ...
Intelectual Property (IP)
It It The The decision was precedential and authored by Judge Cunningham. Aside from the question about Judge Newman’s treatment by the court, Miller Mendel ...
Intelectual Property (IP)
Patent Term Adjustment Traps to Avoid for Practitioners
“We, the patent community…should work together to incrementally improve our system and find and fix rules that are not working as intended.” Patent Term Adjustment ...
Employment
FTC appeals Texas Federal Court’s decision to halt its noncompete ban nationally
On 18 October 2024, the Federal Trade Commission (FTC) gave notice that it was appealing a Texas federal judge’s decision to stop its non-compete regulation ...
Intelectual Property (IP)
DLA Piper
Teva Branded Pharma. Prods. R&D v. Amneal Pharms. The US District Court for the District of New Jersey, in N.Y., LLC, ordered Teva delist five ...